Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE256.1700
- TODAY'S CHANGE (%)-3.0000 (-1.1575%)
- Bid / Lots256.6900/ 1
- Ask / Lots259.6100/ 1
- Open / Previous Close260.0000 / 259.1700
- Day Range
- 52 Week Range
- Volume292,365
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 1355 | 260 |
| 09:34 ET | 225 | 262.25 |
| 09:39 ET | 200 | 259 |
| 09:41 ET | 1689 | 260.46 |
| 09:43 ET | 16708 | 260 |
| 09:45 ET | 100 | 260.07 |
| 09:48 ET | 500 | 260.515 |
| 09:50 ET | 597 | 257.63 |
| 09:52 ET | 200 | 256.95 |
| 09:54 ET | 100 | 259.5 |
| 09:56 ET | 150 | 259.8599 |
| 09:57 ET | 100 | 257.16 |
| 09:59 ET | 900 | 257.805 |
| 10:01 ET | 300 | 259.61 |
| 10:03 ET | 1487 | 259.6 |
| 10:06 ET | 360 | 258.54 |
| 10:08 ET | 315 | 258.48 |
| 10:10 ET | 1791 | 257.575 |
| 10:12 ET | 100 | 258.32 |
| 10:14 ET | 754 | 257 |
| 10:15 ET | 800 | 255 |
| 10:17 ET | 600 | 254.895 |
| 10:19 ET | 500 | 255.905 |
| 10:26 ET | 620 | 257.08 |
| 10:28 ET | 600 | 257.6 |
| 10:30 ET | 100 | 257.71 |
| 10:32 ET | 100 | 257.72 |
| 10:35 ET | 100 | 257.52 |
| 10:37 ET | 2193 | 256.71 |
| 10:39 ET | 600 | 257.025 |
| 10:42 ET | 950 | 256.99 |
| 10:44 ET | 100 | 257.3 |
| 10:46 ET | 100 | 257.35 |
| 10:48 ET | 300 | 256.93 |
| 10:53 ET | 100 | 256.44 |
| 11:00 ET | 500 | 256.635 |
| 11:04 ET | 100 | 256.475 |
| 11:06 ET | 100 | 257.05 |
| 11:08 ET | 1100 | 258.31 |
| 11:09 ET | 250 | 258.1 |
| 11:11 ET | 692 | 257.945 |
| 11:13 ET | 900 | 256.91 |
| 11:15 ET | 535 | 257.274 |
| 11:18 ET | 100 | 256.5 |
| 11:20 ET | 100 | 257.15 |
| 11:24 ET | 300 | 257.055 |
| 11:26 ET | 300 | 257.505 |
| 11:27 ET | 201 | 257.98 |
| 11:38 ET | 100 | 257.62 |
| 11:44 ET | 800 | 256.93 |
| 11:45 ET | 941 | 256.1 |
| 11:49 ET | 518 | 255.56 |
| 12:02 ET | 200 | 255.035 |
| 12:03 ET | 761 | 254.035 |
| 12:05 ET | 875 | 254.49 |
| 12:07 ET | 304 | 254.39 |
| 12:14 ET | 2161 | 253.53 |
| 12:16 ET | 1153 | 252.67 |
| 12:18 ET | 100 | 252.27 |
| 12:21 ET | 100 | 253.45 |
| 12:23 ET | 700 | 252.8 |
| 12:27 ET | 2100 | 252.665 |
| 12:30 ET | 300 | 253 |
| 12:32 ET | 469 | 253.137 |
| 12:34 ET | 250 | 253.55 |
| 12:38 ET | 500 | 253.89 |
| 12:43 ET | 200 | 255.38 |
| 12:45 ET | 100 | 254.84 |
| 12:48 ET | 533 | 254.79 |
| 12:50 ET | 100 | 254.905 |
| 12:52 ET | 100 | 254.78 |
| 12:56 ET | 1875 | 255.2075 |
| 12:57 ET | 505 | 255.55 |
| 12:59 ET | 100 | 254.72 |
| 01:01 ET | 1796 | 255.33 |
| 01:03 ET | 300 | 254.79 |
| 01:10 ET | 400 | 255.48 |
| 01:12 ET | 100 | 255.85 |
| 01:15 ET | 100 | 255.525 |
| 01:19 ET | 506 | 256 |
| 01:21 ET | 790 | 256.679 |
| 01:30 ET | 200 | 256.51 |
| 01:35 ET | 100 | 256.98 |
| 01:39 ET | 350 | 257.99 |
| 01:42 ET | 3809 | 257.19 |
| 01:44 ET | 100 | 256.64 |
| 01:46 ET | 2871 | 256.585 |
| 01:48 ET | 200 | 256.585 |
| 01:50 ET | 2400 | 257 |
| 01:51 ET | 1500 | 257 |
| 01:53 ET | 970 | 257.305 |
| 01:55 ET | 201 | 257.315 |
| 02:00 ET | 100 | 258.1 |
| 02:02 ET | 2013 | 257.495 |
| 02:04 ET | 414 | 258.06 |
| 02:06 ET | 200 | 257.945 |
| 02:08 ET | 200 | 257.975 |
| 02:09 ET | 100 | 258.185 |
| 02:11 ET | 200 | 258.69 |
| 02:13 ET | 100 | 258.345 |
| 02:15 ET | 230 | 258.365 |
| 02:18 ET | 100 | 258.375 |
| 02:24 ET | 200 | 259 |
| 02:27 ET | 400 | 258.53 |
| 02:29 ET | 300 | 258.46 |
| 02:38 ET | 210 | 258.34 |
| 02:45 ET | 100 | 257.99 |
| 02:51 ET | 510 | 257.88 |
| 02:54 ET | 400 | 258.21 |
| 03:00 ET | 200 | 258.14 |
| 03:02 ET | 100 | 257.545 |
| 03:05 ET | 8848 | 256.175 |
| 03:07 ET | 125 | 256.48 |
| 03:14 ET | 100 | 256.98 |
| 03:18 ET | 300 | 256.61 |
| 03:20 ET | 200 | 256.8 |
| 03:25 ET | 100 | 256.03 |
| 03:27 ET | 100 | 256.16 |
| 03:30 ET | 100 | 256.135 |
| 03:34 ET | 100 | 256.69 |
| 03:39 ET | 576 | 256.7 |
| 03:41 ET | 100 | 257.23 |
| 03:48 ET | 202 | 256.07 |
| 03:50 ET | 300 | 256.43 |
| 03:52 ET | 300 | 256.725 |
| 03:54 ET | 800 | 257.245 |
| 03:56 ET | 800 | 256.03 |
| 03:57 ET | 5062 | 255.24 |
| 03:59 ET | 20975 | 256.17 |
Aug 8, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Buy by Citigroup, from 3:32PM ET on Thursday Aug 08, 2024 by Dow Jones
3:32PM ET on Thursday Aug 08, 2024 by Dow JonesDJ Madrigal Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group, from 9:19AM ET on Thursday Aug 08, 2024 by Dow Jones
9:19AM ET on Thursday Aug 08, 2024 by Dow Jones
Aug 7, 2024
*DJ Madrigal Pharmaceuticals 2Q Loss/Shr $7.10 >MDGL, from 7:00AM ET on Wednesday Aug 07, 2024 by Dow Jones
7:00AM ET on Wednesday Aug 07, 2024 by Dow JonesMadrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates, from 7:00AM ET on Wednesday Aug 07, 2024 by Dow Jones
7:00AM ET on Wednesday Aug 07, 2024 by Dow Jones
Aug 2, 2024
Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel, from 7:00AM ET on Friday Aug 02, 2024 by Dow Jones
7:00AM ET on Friday Aug 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 5.6B | -10.0x | --- |
Avidity Biosciences Inc | 5.2B | -15.2x | --- |
Krystal Biotech Inc | 5.7B | 55.2x | --- |
Nuvalent Inc | 4.9B | -29.7x | --- |
BridgeBio Pharma Inc | 4.8B | -9.7x | --- |
Dyne Therapeutics Inc | 4.7B | -13.1x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- General Counsel
- Shannon Kelley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.6B |
|---|---|
Revenue (TTM) | $14.6M |
Shares Outstanding | 21.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.43 |
EPS | $-25.50 |
Book Value | $20.39 |
P/E Ratio | -10.0x |
Price/Sales (TTM) | 384.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,622.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
